Find a Trial
Trial Summary
| Protocol No. | PHO-COG-ANBL1531 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Batra, Sandeep | ||
| Scope | National | ||
| Phase | Phase III | ||
| Age Group | Adults and Children | ||
| Title | A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379) | ||
| Applicable Disease Sites | Soft Tissue | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Melissa Lee, | Phone: +1 317-944-4281 Pager: 312-1228 Email: mellee@iu.edu | |